Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: Alan C. Zezula who wrote (577)	9/28/1998 6:27:00 PM
From: samcat9	Read Replies (1) \| Respond to of 710

If I knew how low is low, I would do very well... but I don't know that. I doubt if CTEC will hit 4. I think it has already hit its low, which was 4 1/4, as I recall. Although I personally like CTEC very much at these prices, there are mixed opinions about it. CTEC was really too high when you bought it, because the price was based on future earnings projections. Future earnings projections have been substantially lowered (too low, in my opinion, based on one quarter of missed earnings). As CTEC price rise was based on high future earnings projections, when one of those earnings estimated failed to materialize (in my opinion, because of one-time results), the analysts killed the stock. I look for a very positive earnings statement for the current quarter, much above the Yahoo estimates. Ameritrade research has the current quarter and year much above the $.05 and $.14 earning estimate provided by Yahoo. As I recall, Ameritrade had the current quarterly estimate at either $.07 or $.08 and the annual estimate at $.20 per share. I'll research the above again if you ask me to. FYI, CTEC's earnings are substantially locked in. Sept. is the last month for the current quarter. THE CAT